Therefore, in the present study, our aim was to expand previous findings, and to further characterize plasma NTA-tau by investigating how AD-related cerebral pathological changes (Aβ pathology, tau pathology, and neurodegeneration) may drive the increase of these NTA-tau in blood. Here, MAPT is linked to Alzheimer disease.